Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 5 of 5
  • Some of the metrics are blocked by your 
    Item type:Publication,
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Identifying Risk Factors for Impaired Pulmonary Function in COVID-19 Patients: Cross-Sectional Study
    (Mongolian National University of Medical Sciences, 2025-03-31)
    Bayaraa, Odonchimeg
    ;
    ; ; ;
    Objective: COVID-19 has an impact on various organs, including heart, kidney, lung, and liver. However, respiratory system has been the primary organ mostly affected, ranging from asymp tomatic to critical stages of the disease. The risk of developing impaired pulmonary function depends on multiple factors, including demographic and clinical manifestations such as severi ty of the disease, comorbidities, and treatment options. As the number of new COVID-19 cases declines, public health experts and medical doctors are increasingly interested in conditions after COVID-19 and are working to improve the quality of life for affected patients. Our study aim was to investigate risk factors associated with impaired pulmonary function in individuals recovered from severe COVID-19. Method: The study was conducted using a hospital-based, cross-sectional study design. A total of 268 participants who visited the Pulmonology and Allergology Center of The First Central Hospital of Mongolia for a follow-up examination one year after contracting COVID-19 between 2022 and 2023. Demographic data, comorbidities, severity of initial infection, hospitalization history, and spirometry were analyzed to determine their association with post-COVID-19 impairment of pulmonary function. Results: This study identified the risk factors significantly associated with altered pulmonary function in post COVID-19. 50.4% of individuals with initial severe infection had altered pulmonary function. Severe group had higher odds of decreasing FVC (predicted %) compared to the asymptomatic group (OR=3.69; 95% CI; P =0.003). For comorbidities, patients with cardiovascular disease were significantly more likely to decrease FVC (predicted %) compared to participants who had no comorbidities (OR=4.22; 95% CI; P =0.040). Moreover, patients with chronic lung diseases had a significantly high of impaired FVC (%), with an adjusted odds ratio of 2.46 (95% CI, P =0.005) Conclusion: Patients with pre-existing cardiovascular and chronic lung diseases, and severe initial infection have a significantly higher likelihood of impaired pulmonary function compared to those with other comorbidities, and non-severe COVID-19.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    SNP-SNP positive interaction between MMP2 and MMP12 increases the risk of COPD
    Determining SNP-SNP interaction of the disease has become important for further investigation of pathogenesis and experimental research. Although many studies have been published on the effect of MMPs gene polymorphisms on chronic obstructive pulmonary disease (COPD), there is a lack of information on SNP-SNP and SNP-environment interactions. This study aimed to investigate the interaction between the polymorphisms of MMP1, MMP2, MMP9 and MMP12 genes and its combined effect with smoking on the risk of developing COPD. Totally 181 COPD patients and 292 healthy individuals were involved. Blood samples from the participants were tested for genotyping and data were collected through questionnaires. Genotyping was performed with nested allele-specific polymerase chain reaction (AS-PCR) and polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). SNP-SNP and SNP-environment interactions were investigated using multifactor dimensionality reduction and logistic regression analysis. The result showed that participants with high nicotine dependence and heavy smokers had a higher risk of COPD than non-smokers. Also, G/G genotype (cOR = 5.83; 95% CI, 1.19-28.4, p = 0.029) of MMP2 rs243864 and T/T genotype (cOR = 1.79; 95% CI, 1.16-2.76, p = 0.008) of MMP12 rs652438 independently contributes to the susceptibility of COPD. For SNP-SNP interaction, the positive interaction between rs243864 G/G genotype of MMP2 and rs652438 T/T genotype of MMP12 was found, and the combination of risk genotypes has a high risk of COPD (OR = 12.92; 95% CI, 1.46-114.4, p = 0.021). Moreover, the combination of T/T genotype of MMP12 rs652438 and smoking-related factors increases the risk of COPD approximately 4.5 to 6-fold. The results suggests that there is a combination of MMP2, MMP12, and smoking-related factors may increase the risk of developing COPD.
    Scopus© Citations 3
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The synergistic interaction between ACE and TMPRSS2 polymorphisms increases the risk of severe COVID-19
    (Public Library of Science (PLoS), 2026)
    Bayaraa, Odonchimeg
    ;
    ; ; ;
    Within a few years after the pandemic outbreak, several of evidence have found to suggest that the genetic factors influence the severity and mortality rate of COVID-19. In particular, the identification of genetic markers that increase the risk of severe or critical COVID-19 is important for public health management during the pandemic. By August 2021, 88.9% of Mongolian population had been vaccinated. Therefore, we conducted this study to compare the polymorphisms of candidate genes by selecting people who developed mild or severe COVID-19 within this vaccinated population. A total of 90 patients with severe COVID-19, 95 patients with mild COVID-19, and 90 asymptomatic patients were participated in present cross-sectional study. rs4646994, rs4240157, rs41423247, rs56149945, rs10052957, rs12329760, rs4303795, rs75603675 and rs17854725 polymorphisms of the ACE, ACE2, NR3C1 and TMPRSS2 genes were genotyped. Genotyping performed by real-time PCR, RFLP and allele-specific PCR methods. Odds ratio, 95% confidence interval, p value were calculated using logistic regression analysis. SNP-SNP interaction were explored using multi-dimensional reduction analysis. P values for multivariate model was corrected by Bonferroni correction. Totally 10 polymorphisms of above-mentioned genes were genotyped among the groups. Only A/C genotype frequencies of rs75603675 were significantly different between groups. Compared with mild COVID-19 group, the participants who carrying A/C genotype of rs75603675 had 3.58-fold (95% CI, 1.38-9.29, p = 0.009) higher risk for severe COVID-19. In addition, the synergistic interaction (RERI = 2.573; AP = 0.934; S = 8.352) was observed between D/D or I/D genotype of rs4646994 and A/C genotype of rs75603675, which combination (OR=4.88, 95% CI, 1.38-18.01, p = 0.014, Power = 91.1%) was associated with increased risk of severe COVID-19 after Bonferroni correction. Our result suggesting that the combination of rs4646994 of the ACE gene and rs75603675 of the TMPRSS2 gene is associated with increased risk of severe COVID-19.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The Cumulative Effect of Gene-Gene Interactions Between GSTM1, CHRNA3, CHRNA5 and SOD3 Gene Polymorphisms Combined with Smoking on COPD Risk
    (Informa UK Limited, 2021) ; ;
    Tumurbaatar, Ariuntungalag
    ;
    ;
    Enebish, Tseepil
    BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a multifactorial disorder which is affected by external and internal risk factors. People with no external risk factors may be significantly affected and develop pulmonary disease. The study aimed to define gene-gene and gene-environmental effects on COPD. METHODS: A case control study involved 181 COPD patients and 292 healthy individuals, with peripheral blood sampling and adequate questionnaires. Genotyping was done with various types of PCR design for GSTM1 (null del), GSTT1 (null del), EPHX1 (rs2234922 and rs1051740), GSTP1 (rs1695 and rs1138272), CHRNA3 (rs1051730 and rs12914385), CHRNA5 (rs16969968 and rs17486278), and SOD3 (rs1799895 and rs699473) gene polymorphisms. Gene-gene and gene-environmental interactions were investigated using multidimensional regression analysis. RESULTS: Frequency of risk alleles of rs1051730 (p = 0.001), rs16969968 (p <0.001), and rs1799895 (p <0.001) polymorphisms were significant in univariate analysis. For gene-gene interaction, GSTM1 null, rs1051730, rs16969968, and rs1799895 polymorphisms independently contributed to risk of COPD and any combinations of the risk genotypes have a higher risk of disease. A cumulative effect of the four risk polymorphisms increased the risk of COPD for the smoking index (cOR = 13.6, p <0.001), cigarettes per day (cOR = 32.08, p <0.01), nicotine dependence (cOR = 12.0, p <0.01), and smoking status (cOR = 17.02, p <0.01) for gene-environmental interaction. CONCLUSION: Several pivotal genes showed distinct effects for COPD, and some synergistic effects affected the disease progression. The development of COPD was synergistically increased with gene-gene and gene-environmental risk factors.
    Scopus© Citations 14